MEDIOS AG (ILM1.DE) Stock Fundamental Analysis

FRA:ILM1 • DE000A1MMCC8

16.68 EUR
-0.56 (-3.25%)
Last: Feb 20, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

ILM1 gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 29 industry peers in the Health Care Providers & Services industry. ILM1 has a great financial health rating, but its profitability evaluates not so good. ILM1 is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year ILM1 was profitable.
  • ILM1 had a positive operating cash flow in the past year.
  • In the past 5 years ILM1 has always been profitable.
  • Of the past 5 years ILM1 4 years had a positive operating cash flow.
ILM1.DE Yearly Net Income VS EBIT VS OCF VS FCFILM1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

1.2 Ratios

  • With a Return On Assets value of 2.34%, ILM1 perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
  • ILM1 has a Return On Equity of 4.25%. This is in the lower half of the industry: ILM1 underperforms 65.63% of its industry peers.
  • The Return On Invested Capital of ILM1 (3.73%) is worse than 65.63% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ILM1 is below the industry average of 6.14%.
  • The 3 year average ROIC (3.26%) for ILM1 is below the current ROIC(3.73%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.34%
ROE 4.25%
ROIC 3.73%
ROA(3y)2.56%
ROA(5y)2.39%
ROE(3y)3.52%
ROE(5y)3.26%
ROIC(3y)3.26%
ROIC(5y)3.09%
ILM1.DE Yearly ROA, ROE, ROICILM1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

  • ILM1's Profit Margin of 1.09% is on the low side compared to the rest of the industry. ILM1 is outperformed by 62.50% of its industry peers.
  • In the last couple of years the Profit Margin of ILM1 has declined.
  • With a Operating Margin value of 2.21%, ILM1 is not doing good in the industry: 81.25% of the companies in the same industry are doing better.
  • ILM1's Operating Margin has declined in the last couple of years.
  • The Gross Margin of ILM1 (9.66%) is worse than 65.63% of its industry peers.
  • In the last couple of years the Gross Margin of ILM1 has grown nicely.
Industry RankSector Rank
OM 2.21%
PM (TTM) 1.09%
GM 9.66%
OM growth 3Y14.45%
OM growth 5Y-8.47%
PM growth 3Y6.91%
PM growth 5Y-18.81%
GM growth 3Y16.82%
GM growth 5Y4.08%
ILM1.DE Yearly Profit, Operating, Gross MarginsILM1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ILM1 is destroying value.
  • Compared to 1 year ago, ILM1 has more shares outstanding
  • The number of shares outstanding for ILM1 has been increased compared to 5 years ago.
  • Compared to 1 year ago, ILM1 has a worse debt to assets ratio.
ILM1.DE Yearly Shares OutstandingILM1.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ILM1.DE Yearly Total Debt VS Total AssetsILM1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • ILM1 has an Altman-Z score of 3.26. This indicates that ILM1 is financially healthy and has little risk of bankruptcy at the moment.
  • ILM1's Altman-Z score of 3.26 is amongst the best of the industry. ILM1 outperforms 87.50% of its industry peers.
  • ILM1 has a debt to FCF ratio of 2.17. This is a good value and a sign of high solvency as ILM1 would need 2.17 years to pay back of all of its debts.
  • ILM1 has a better Debt to FCF ratio (2.17) than 96.88% of its industry peers.
  • A Debt/Equity ratio of 0.32 indicates that ILM1 is not too dependend on debt financing.
  • ILM1 has a better Debt to Equity ratio (0.32) than 90.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 2.17
Altman-Z 3.26
ROIC/WACC0.55
WACC6.81%
ILM1.DE Yearly LT Debt VS Equity VS FCFILM1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • A Current Ratio of 1.74 indicates that ILM1 should not have too much problems paying its short term obligations.
  • ILM1 has a better Current ratio (1.74) than 81.25% of its industry peers.
  • ILM1 has a Quick Ratio of 1.31. This is a normal value and indicates that ILM1 is financially healthy and should not expect problems in meeting its short term obligations.
  • ILM1's Quick ratio of 1.31 is amongst the best of the industry. ILM1 outperforms 81.25% of its industry peers.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 1.31
ILM1.DE Yearly Current Assets VS Current LiabilitesILM1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • ILM1 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.63%, which is quite impressive.
  • The Earnings Per Share has been decreasing by -5.00% on average over the past years.
  • ILM1 shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.27%.
  • ILM1 shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.51% yearly.
EPS 1Y (TTM)63.63%
EPS 3Y11.33%
EPS 5Y-5%
EPS Q2Q%80.36%
Revenue 1Y (TTM)9.27%
Revenue growth 3Y11.53%
Revenue growth 5Y29.51%
Sales Q2Q%9.13%

3.2 Future

  • The Earnings Per Share is expected to grow by 19.17% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 2.79% on average over the next years.
EPS Next Y5.3%
EPS Next 2Y17.64%
EPS Next 3Y19.17%
EPS Next 5YN/A
Revenue Next Year8.28%
Revenue Next 2Y5.99%
Revenue Next 3Y5.37%
Revenue Next 5Y2.79%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ILM1.DE Yearly Revenue VS EstimatesILM1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B
ILM1.DE Yearly EPS VS EstimatesILM1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 19.17, the valuation of ILM1 can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of ILM1 is on the same level as its industry peers.
  • ILM1's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.99.
  • The Price/Forward Earnings ratio is 11.92, which indicates a very decent valuation of ILM1.
  • Based on the Price/Forward Earnings ratio, ILM1 is valued cheaply inside the industry as 81.25% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, ILM1 is valued rather cheaply.
Industry RankSector Rank
PE 19.17
Fwd PE 11.92
ILM1.DE Price Earnings VS Forward Price EarningsILM1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ILM1 indicates a rather cheap valuation: ILM1 is cheaper than 87.50% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, ILM1 is valued cheaply inside the industry as 84.38% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 4.66
EV/EBITDA 6.42
ILM1.DE Per share dataILM1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • ILM1's earnings are expected to grow with 19.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.62
PEG (5Y)N/A
EPS Next 2Y17.64%
EPS Next 3Y19.17%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ILM1!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MEDIOS AG

FRA:ILM1 (2/20/2026, 7:00:00 PM)

16.68

-0.56 (-3.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-11
Earnings (Next)03-26
Inst Owners39.25%
Inst Owner ChangeN/A
Ins Owners19.7%
Ins Owner ChangeN/A
Market Cap425.51M
Revenue(TTM)2.01B
Net Income(TTM)22.03M
Analysts87.27
Price Target24.48 (46.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.69%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.32%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.98%
Valuation
Industry RankSector Rank
PE 19.17
Fwd PE 11.92
P/S 0.21
P/FCF 4.66
P/OCF 4.31
P/B 0.82
P/tB 15.48
EV/EBITDA 6.42
EPS(TTM)0.87
EY5.22%
EPS(NY)1.4
Fwd EY8.39%
FCF(TTM)3.58
FCFY21.45%
OCF(TTM)3.87
OCFY23.21%
SpS78.89
BVpS20.31
TBVpS1.08
PEG (NY)3.62
PEG (5Y)N/A
Graham Number19.94
Profitability
Industry RankSector Rank
ROA 2.34%
ROE 4.25%
ROCE 6.15%
ROIC 3.73%
ROICexc 4.29%
ROICexgc 19.24%
OM 2.21%
PM (TTM) 1.09%
GM 9.66%
FCFM 4.54%
ROA(3y)2.56%
ROA(5y)2.39%
ROE(3y)3.52%
ROE(5y)3.26%
ROIC(3y)3.26%
ROIC(5y)3.09%
ROICexc(3y)3.82%
ROICexc(5y)3.8%
ROICexgc(3y)12.89%
ROICexgc(5y)11.48%
ROCE(3y)5.38%
ROCE(5y)5.1%
ROICexgc growth 3Y-0.85%
ROICexgc growth 5Y-8.22%
ROICexc growth 3Y-6.07%
ROICexc growth 5Y-23.77%
OM growth 3Y14.45%
OM growth 5Y-8.47%
PM growth 3Y6.91%
PM growth 5Y-18.81%
GM growth 3Y16.82%
GM growth 5Y4.08%
F-Score7
Asset Turnover2.14
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 2.17
Debt/EBITDA 2.04
Cap/Depr 19.67%
Cap/Sales 0.37%
Interest Coverage 3.48
Cash Conversion 119.67%
Profit Quality 414.43%
Current Ratio 1.74
Quick Ratio 1.31
Altman-Z 3.26
F-Score7
WACC6.81%
ROIC/WACC0.55
Cap/Depr(3y)16.31%
Cap/Depr(5y)50.4%
Cap/Sales(3y)0.24%
Cap/Sales(5y)0.49%
Profit Quality(3y)264.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.63%
EPS 3Y11.33%
EPS 5Y-5%
EPS Q2Q%80.36%
EPS Next Y5.3%
EPS Next 2Y17.64%
EPS Next 3Y19.17%
EPS Next 5YN/A
Revenue 1Y (TTM)9.27%
Revenue growth 3Y11.53%
Revenue growth 5Y29.51%
Sales Q2Q%9.13%
Revenue Next Year8.28%
Revenue Next 2Y5.99%
Revenue Next 3Y5.37%
Revenue Next 5Y2.79%
EBIT growth 1Y59.29%
EBIT growth 3Y27.64%
EBIT growth 5Y18.54%
EBIT Next Year99.82%
EBIT Next 3Y34.09%
EBIT Next 5Y29.68%
FCF growth 1Y229.48%
FCF growth 3Y11.42%
FCF growth 5YN/A
OCF growth 1Y228.59%
OCF growth 3Y6.19%
OCF growth 5YN/A

MEDIOS AG / ILM1.DE FAQ

What is the fundamental rating for ILM1 stock?

ChartMill assigns a fundamental rating of 5 / 10 to ILM1.DE.


What is the valuation status of MEDIOS AG (ILM1.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to MEDIOS AG (ILM1.DE). This can be considered as Fairly Valued.


How profitable is MEDIOS AG (ILM1.DE) stock?

MEDIOS AG (ILM1.DE) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for ILM1 stock?

The Earnings per Share (EPS) of MEDIOS AG (ILM1.DE) is expected to grow by 5.3% in the next year.


How sustainable is the dividend of MEDIOS AG (ILM1.DE) stock?

The dividend rating of MEDIOS AG (ILM1.DE) is 0 / 10 and the dividend payout ratio is 0%.